Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%

Erin M. Warshaw; Katherine R. St Clair

doi:10.1016/j.jaad.2005.06.019

Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%

Erin M. Warshaw, Katherine R. St Clair

Dermatology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.

Original language	English (US)
Pages (from-to)	717-720
Number of pages	4
Journal	Journal of the American Academy of Dermatology
Volume	53
Issue number	4
DOIs	https://doi.org/10.1016/j.jaad.2005.06.019
State	Published - Oct 2005

Bibliographical note

Funding Information:
Funding source: Coloplast Corp, Skin Health Division, through a generous, unrestricted research grant. Dr Warshaw's career has been supported by a VA Cooperative Studies Clinical Research Career Development Grant.

Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.

Access

10.1016/j.jaad.2005.06.019

Fingerprint Dive into the research topics of 'Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%'. Together they form a unique fingerprint.

Cite this

Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails : Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%. / Warshaw, Erin M.; St Clair, Katherine R.

In: Journal of the American Academy of Dermatology, Vol. 53, No. 4, 10.2005, p. 717-720.

Research output: Contribution to journal › Article › peer-review

@article{7061637aae074bfdb7822aea430dff6b,

title = "Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%",

abstract = "The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.",

author = "Warshaw, {Erin M.} and {St Clair}, {Katherine R.}",

note = "Funding Information: Funding source: Coloplast Corp, Skin Health Division, through a generous, unrestricted research grant. Dr Warshaw's career has been supported by a VA Cooperative Studies Clinical Research Career Development Grant. Copyright: Copyright 2008 Elsevier B.V., All rights reserved.",

year = "2005",

month = oct,

doi = "10.1016/j.jaad.2005.06.019",

language = "English (US)",

volume = "53",

pages = "717--720",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "4",

}

TY - JOUR

T1 - Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails

T2 - Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%

AU - Warshaw, Erin M.

AU - St Clair, Katherine R.

N1 - Funding Information: Funding source: Coloplast Corp, Skin Health Division, through a generous, unrestricted research grant. Dr Warshaw's career has been supported by a VA Cooperative Studies Clinical Research Career Development Grant. Copyright: Copyright 2008 Elsevier B.V., All rights reserved.

PY - 2005/10

Y1 - 2005/10

N2 - The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.

AB - The objective of this 2-year, double-blind, placebo-controlled, randomized trial involving 48 participants was to determine if biweekly miconazole powder prevents onychomycosis recurrence. Intent-to-treat analysis found no significant differences in mycologic, clinical, or complete onychomycosis reinfection rates or time to reinfection. Limitations include small sample size and dosing regimen.

UR - http://www.scopus.com/inward/record.url?scp=25844474480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844474480&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2005.06.019

DO - 10.1016/j.jaad.2005.06.019

M3 - Article

C2 - 16198805

AN - SCOPUS:25844474480

VL - 53

SP - 717

EP - 720

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -

Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%

Abstract

Bibliographical note

Access

Other files and links

Cite this